Mirae Asset Global ETFs Holdings’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$586K Sell
41,798
-7,478
-15% -$105K ﹤0.01% 1738
2025
Q1
$669K Buy
49,276
+876
+2% +$11.9K ﹤0.01% 1707
2024
Q4
$930K Buy
48,400
+13,990
+41% +$269K ﹤0.01% 1581
2024
Q3
$783K Buy
34,410
+2,920
+9% +$66.4K ﹤0.01% 1676
2024
Q2
$408K Buy
+31,490
New +$408K ﹤0.01% 1913